Search

In the present paper, a novel composite Graphene–Gold (Gr–Au)/TiO2–SiO2 photocatalyst was synthesized and tested for the removal of methylene blue and rhodamine B in water solutions. First, Gr–Au nanoparticle composite was synthesized by simultaneous reduction and deposition of Au nanoparticles on Gr surface. The photodegradation of methylene blue and rhodamine B in aqueous solutions was studied using various photocatalysts, including neat TiO2–SiO2, Gr/TiO2–SiO2 and Gr–Au/TiO2–SiO2 composites. The Gr weight ratio in this research is 2% in the Gr/TiO2–SiO2 composites. Detailed characterization (field emission scanning electron microscope, Raman, Fourier transform infrared spectra and UV–vis absorbance spectroscopy) of such material was conducted. As a result, the uniform deposition of nanometer-sized Au NPs on the graphene sheets was observed. The Gr–Au/TiO2–SiO2 exhibited excellent photocatalytic efficiency because of the reduction of electron–hole recombination. The Gr2%–Au0.1%/TiO2–SiO2 composite had the highest photoactivity. [ABSTRACT FROM AUTHOR]

Cancer cells are able to release high amounts of extracellular vesicles, thereby conditioning the normal cells in the surrounding tissue and/or in distant target organs. In the context of bone cancers, previous studies suggested that osteosarcoma cancer cells produce transforming extracellular vesicles able to induce a tumour-like phenotype in normal recipient cells. Indeed, phosphoinositide-specific phospholipase C (PI-PLC) enzymes are differentially expressed in osteosarcoma cell lines with increasing aggressiveness, thus providing helpful insights to better define their role and functions in this bone tumour. By confocal microscopy analysis, we demonstrated that osteosarcoma-derived extracellular vesicles convey all the assessed PI-PLC isoforms, and that they localize into cell membrane bubble-like structures, resembling extracellular vesicles about to be released, as conveyed and/or membrane protein. Cytofluorimetric analysis confirmed the presence of PI-PLC isoforms in the extracellular vesicles collected from conditioned media of osteosarcoma cells. These findings suggest the feasibility to use circulating extracellular vesicles as biomarkers of osteosarcoma progression and/or the monitoring of this distressing disease. [ABSTRACT FROM AUTHOR]

TiO2-SiO2 mixed oxides have been prepared by the sol-gel technique from tetrabutyl orthotitanate and tetraethyl orthosilicate. The prepared materials were characterized by x-ray diffraction, scanning electron microscopy, energy dispersive x-ray spectroscopy, nitrogen physisorption, Fourier-transform infrared spectroscopy (FT-IR) and x-ray photoelectron spectroscopy (XPS). The results indicate that the TiO2-SiO2 mixed oxides have a large surface area and a nanoscale size. FT-IR spectra show that Ti atoms are bonded to silica by oxygen bridging atoms in Ti-O-Si bonds. The titanium valence states in TiO2-SiO2 mixed oxides were investigated by XPS, and their spectra report the presence of Ti2+ and Ti3+ cations for high silica concentration, suggesting the formation of oxygen vacancies. The photocatalytic activity of the prepared materials has been evaluated for the photodegradation of methylene blue (MB). The mixed oxides were activated by means of a UV light source, and the concentration of MB was monitored by UV-Vis spectroscopy. The synthesized TiO2-SiO2 shows significantly higher MB removal efficiency in comparison with that of the commercial TiO2 Degussa, P25. [ABSTRACT FROM AUTHOR]

Pyrolysis is a fundamental step in thermochemical processes of biomass materials, so a suitable kinetic model is an essential tool to predict the evolution of the resulting products of reaction. However, many difficulties arise in modeling this process step due to the very high number of the involved reactions. In this work, a new double-Gaussian distributed activation energy model was applied in fitting the experimental data of olive residue pyrolysis obtained by thermogravimetric analysis. 2-DAEM formulation considers two sets of parallel reactions occurring and sharing the same pre-exponential factor, but shows different distributions of the activation energy, described by two separate Gaussian distributions that, in turn, grasp the two pyrolysis steps with a high accuracy. Since it is well known that in fitting all the kinetic parameters the pre-exponential factor results highly correlated with the activation energy, the former parameter was separately estimated as a linear combination of the values obtained for the three main biomass components, cellulose, hemicellulose and lignin. [ABSTRACT FROM AUTHOR]

We have recently reported that bcl-2 overexpression and hypoxia synergistically interact to modulate vascular endothelial growth factor (VEGF) and in vivo angiogenesis in tumour cells through VEGF mRNA stabilization and hypoxia-inducible factor 1-mediated transcriptional activity. Bcl-2 antisense treatment has shown promising clinical results in patients with malignant melanoma. In the present study, we demonstrated that the bcl-2/bcl-xL bispecific antisense oligonucleotide 4625 inhibits bcl-2 expression and angiogenesis in two bcl-2 overexpressing clones derived from the M14 human melanoma cell line. The antiangiogenic effect was determined in in vitro and in vivo angiogenesis assays. In particular, a reduction of hypoxia-induced VEGF secretion was observed after 4625 treatment, and the conditioned medium (CM) of bcl-2 overexpressing clones treated with 4625 and exposed to hypoxic conditions resulted in decreased endothelial cell proliferation when compared to CM of untreated control cells. In addition, we found that CM of 4625 antisense-treated bcl-2 transfectants inhibited in vivo vessel formation in matrigel plugs implanted subcutaneously in C57/B16 mice. Our findings confirm that bcl-2 plays a crucial role in melanoma angiogenesis and demonstrate for the first time that downregulation of bcl-2 by antisense treatment has potential to inhibit angiogenesis independent of its effect on cell survival. The use of 4625 in cancer therapy is suggested as an approach to facilitate simultaneously tumour cell apoptosis and inhibit tumour angiogenesis.Oncogene (2003) 22, 8441-8447. doi:10.1038/sj.onc.1206999 [ABSTRACT FROM AUTHOR]

Deals with a study which determined the role of telomerase in c-Myc-dependent tumorigenicity of melanoma cells. Effect of c-Myc down-regulation on M14 cell proliferation; Examination of the tumorigenicity ability of c-Myc low-expressing clones; Protocols in reverse transcriptase-polymerase chain reaction.